Trials BioMed Central Study protocol

First Page		Document Content
Smoking Quitline Nicotine replacement therapy Nicotine Anonymous Nicotine patch Varenicline The New York NRT Distribution Program Smoking cessation Ethics Tobacco		Trials BioMed Central Study protocol Add to Reading List Source URL: www.trialsjournal.com Download Document from Source Website File Size: 315,01 KB Share Document on Facebook

	Available: NICOTINE GUM (4 mg) or PATCH (21 mg) and 1:1 and Group Cessation Counseling DocID: 1sYnz - View Document
	Generic Patch Inference Jesper Andersen Julia L. Lawall DIKU, University of Copenhagen, DocID: 1qoUp - View Document
	Guide to Quit Smoking Reasons to Quit How to Quit What Smoking Does to Us DocID: 1qhC4 - View Document
	Smoking Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised openlabel trial H-J Aubin,1 A Bobak,2 J R Britton,3 C Oncken,4 C B Billing Jr,5 J Gong,5 K E Williams,5 K R Reeves5 DocID: 1deGw - View Document
	Comparison Of Current Pharmacotherapy For Nicotine Dependence Treatment** Product OTC Nicotine Patch BRAND NAME DocID: 19yBH - View Document